Foasu Jin Powderwash
Allantoin, Panthenol
Hanscos Co.,ltd.
Human Otc Drug
NDC 77964-005Foasu Jin Powderwash also known as Allantoin, Panthenol is a human otc drug labeled by 'Hanscos Co.,ltd.'. National Drug Code (NDC) number for Foasu Jin Powderwash is 77964-005. This drug is available in dosage form of Powder. The names of the active, medicinal ingredients in Foasu Jin Powderwash drug includes Allantoin - .1 g/100g Panthenol - .01 g/100g . The currest status of Foasu Jin Powderwash drug is Active.
Drug Information:
| Drug NDC: | 77964-005 |
| The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC. |
| Proprietary Name: | Foasu Jin Powderwash |
| Also known as the trade name. It is the name of the product chosen by the labeler. |
| Product Type: | Human Otc Drug |
| Indicates the type of product, such as Human Prescription Drug or Human OTC Drug. This data element corresponds to the “Document Type” of the SPL submission for the listing. |
| Non Proprietary Name: | Allantoin, Panthenol |
| Also known as the generic name, this is usually the active ingredient(s) of the product. |
| Labeler Name: | Hanscos Co.,ltd. |
| Name of Company corresponding to the labeler code segment of the ProductNDC. |
| Dosage Form: | Powder |
| The translation of the DosageForm Code submitted by the firm. There is no standard, but values may include terms like `tablet` or `solution for injection`.The complete list of codes and translations can be found www.fda.gov/edrls under Structured Product Labeling Resources. |
| Status: | Active |
| FDA does not review and approve unfinished products. Therefore, all products in this file are considered unapproved. |
| Substance Name: | ALLANTOIN - .1 g/100g
PANTHENOL - .01 g/100g
|
| This is the active ingredient list. Each ingredient name is the preferred term of the UNII code submitted. |
| Route Details: | TOPICAL
|
| The translation of the Route Code submitted by the firm, indicating route of administration. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources. |
Marketing Information:
An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
| Marketing Category: | UNAPPROVED DRUG OTHER |
| Product types are broken down into several potential Marketing Categories, such as New Drug Application (NDA), Abbreviated New Drug Application (ANDA), BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources. |
| Marketing Start Date: | 27 Feb, 2022 |
| This is the date that the labeler indicates was the start of its marketing of the drug product. |
| Marketing End Date: | 09 May, 2026 |
| This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached. |
| Listing Expiration Date: | 31 Dec, 2023 |
| This is the date when the listing record will expire if not updated or certified by the firm. |
OpenFDA Information:
An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
| Manufacturer Name: | HANSCOS Co.,Ltd.
|
| Name of manufacturer or company that makes this drug product, corresponding to the labeler code segment of the NDC. |
| Original Packager: | Yes
|
| Whether or not the drug has been repackaged for distribution. |
| UPC: | 8809579912781
|
| UPC stands for Universal Product Code. |
| UNII: | 344S277G0Z
WV9CM0O67Z
|
| Unique Ingredient Identifier, which is a non-proprietary, free, unique, unambiguous, non-semantic, alphanumeric identifier based on a substance’s molecular structure and/or descriptive information. |
Packaging Information:
| Package NDC | Description | Marketing Start Date | Marketing End Date | Sample Available |
|---|
| 77964-005-01 | 70 g in 1 CONTAINER (77964-005-01) | 27 Feb, 2022 | N/A | No |
| Package NDC number, known as the NDC, identifies the labeler, product, and trade package size. The first segment, the labeler code, is assigned by the FDA. Description tells the size and type of packaging in sentence form. Multilevel packages will have the descriptions concatenated together. |
Purpose:
Purpose skin protectant
Product Elements:
Foasu jin powderwash allantoin, panthenol water butylene glycol allantoin allantoin panthenol panthenol
Indications and Usage:
Use apply proper amount to the skin, or the enclosed bubble pad, wet it with water, make enough bubbles, massage gently all over the face, and rinse thoroughly with warm water
Warnings:
Warnings for external use only 1) please consult your doctor if you experience side effects such as swelling, itching, or reddening on the area where you applied this product 2) do not apply on wounds or cuts. 3) do not store where children may reach, and avoid keeping it exposed to direct sunlight.
Dosage and Administration:
Directions for external use only
Package Label Principal Display Panel:
Label